BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10602027)

  • 1. Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain.
    Delespine-Carmagnat M; Bouvier G; Bertoglio J
    Eur J Immunol; 2000 Jan; 30(1):59-68. PubMed ID: 10602027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation.
    Friedmann MC; Migone TS; Russell SM; Leonard WJ
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2077-82. PubMed ID: 8700888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule Shc.
    Lord JD; McIntosh BC; Greenberg PD; Nelson BH
    J Immunol; 1998 Nov; 161(9):4627-33. PubMed ID: 9794391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
    Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
    J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T; Ma J; Cao X
    Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. Interleukin-2-dependent mitogenesis does not require Shc phosphorylation or receptor association.
    Evans GA; Goldsmith MA; Johnston JA; Xu W; Weiler SR; Erwin R; Howard OM; Abraham RT; O'Shea JJ; Greene WC
    J Biol Chem; 1995 Dec; 270(48):28858-63. PubMed ID: 7499411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling.
    Ravichandran KS; Igras V; Shoelson SE; Fesik SW; Burakoff SJ
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5275-80. PubMed ID: 8643566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD16-mediated p21ras activation is associated with Shc and p36 tyrosine phosphorylation and their binding with Grb2 in human natural killer cells.
    Galandrini R; Palmieri G; Piccoli M; Frati L; Santoni A
    J Exp Med; 1996 Jan; 183(1):179-86. PubMed ID: 8551221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src-dependent phosphorylation of the EGF receptor Tyr-845 mediates Stat-p21waf1 pathway in A431 cells.
    Sato K; Nagao T; Iwasaki T; Nishihira Y; Fukami Y
    Genes Cells; 2003 Dec; 8(12):995-1003. PubMed ID: 14750954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo.
    Chow JC; Ling PR; Qu Z; Laviola L; Ciccarone A; Bistrian BR; Smith RJ
    Endocrinology; 1996 Jul; 137(7):2880-6. PubMed ID: 8770909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin and interleukin-2 receptors in T lymphocytes signal through a MGF-STAT5-like transcription factor.
    Gouilleux F; Moritz D; Humar M; Moriggl R; Berchtold S; Groner B
    Endocrinology; 1995 Dec; 136(12):5700-8. PubMed ID: 7588326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta chain cytoplasmic domain and suggestion that these residues mediate more than Stat5 activation.
    Ascherman DP; Migone TS; Friedmann MC; Leonard WJ
    J Biol Chem; 1997 Mar; 272(13):8704-9. PubMed ID: 9079703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor.
    Moon JJ; Nelson BH
    J Immunol; 2001 Sep; 167(5):2714-23. PubMed ID: 11509615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the Stat3 signaling pathway is required for differentiation by interleukin-6 in PC12-E2 cells.
    Wu YY; Bradshaw RA
    J Biol Chem; 2000 Jan; 275(3):2147-56. PubMed ID: 10636920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical analysis of interleukin-2 receptor beta chain phosphorylation by p56(lck).
    Delespine-Carmagnat M; Bouvier G; Allée G; Fagard R; Bertoglio J
    FEBS Lett; 1999 Mar; 447(2-3):241-6. PubMed ID: 10214954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes.
    Nielsen M; Svejgaard A; Skov S; Odum N
    Eur J Immunol; 1994 Dec; 24(12):3082-6. PubMed ID: 7528668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
    Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
    Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.